Cardiac-specific PRMT1 ablation induces myocardium hypertrophy and heart attack through CaMKII dysregulation (33), while skeletal muscle–specific Prmt1 KO leads to muscle atrophy via hyperactivated FOXO3 with enhanced energy deprivation (27). This evidence concerns the gene PRMT1 and myocardial infarction.